MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance
Open Access
- 1 January 2018
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 8 (4) , 1106-1120
Abstract
High rates of lethal outcome in tumour metastasis are associated with the acquisition of invasiveness and chemoresistance. Several clinical studies indicate that E2F1 overexpression across high-grade tumours culminates in unfavourable prognosis and chemoresistance in patients. Thus, fine-tuning the expression of E2F1 could be a promising approach for treating patients showing chemoresistance.Keywords
This publication has 54 references indexed in Scilit:
- The UCSC Genome Browser database: extensions and updates 2013Nucleic Acids Research, 2012
- Computational analysis of target hub gene repression regulated by multiple and cooperative miRNAsNucleic Acids Research, 2012
- miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 ProteinJournal of Biological Chemistry, 2011
- MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancerCell Death & Differentiation, 2011
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Nature Medicine, 2011
- VARNA: Interactive drawing and editing of the RNA secondary structureBioinformatics, 2009
- Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplexNature, 2008
- Detecting microRNA binding and siRNA off-target effects from expression dataNature Methods, 2008
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancerProceedings of the National Academy of Sciences, 2008
- Distance constraints between microRNA target sites dictate efficacy and cooperativityNucleic Acids Research, 2007